| UniProt ID | RFIP1_HUMAN | |
|---|---|---|
| UniProt AC | Q6WKZ4 | |
| Protein Name | Rab11 family-interacting protein 1 | |
| Gene Name | RAB11FIP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1283 | |
| Subcellular Localization |
Recycling endosome . Rab11A rather than Rab4A mediates localization in the endocytic recycling compartment (ERC). Isoform 2: Cytoplasmic vesicle, phagosome membrane. Membrane-bound (isoform 2). Colocalizes with Rab11A at phagosomes (isoform 2). |
|
| Protein Description | A Rab11 effector protein involved in the endosomal recycling process. Also involved in controlling membrane trafficking along the phagocytic pathway and in phagocytosis.. | |
| Protein Sequence | MSLMVSAGRGLGAVWSPTHVQVTVLQARGLRAKGPGGTSDAYAVIQVGKEKYATSVSERSLGAPVWREEATFELPSLLSSGPAAAATLQLTVLHRALLGLDKFLGRAEVDLRDLHRDQGRRKTQWYKLKSKPGKKDKERGEIEVDIQFMRNNMTASMFDLSMKDKSRNPFGKLKDKIKGKNKDSGSDTASAIIPSTTPSVDSDDESVVKDKKKKSKIKTLLSKSNLQKTPLSQSMSVLPTSKPEKVLLRPGDFQSQWDEDDNEDESSSASDVMSHKRTASTDLKQLNQVNFTLPKKEGLSFLGGLRSKNDVLSRSNVCINGNHVYLEQPEAKGEIKDSSPSSSPSPKGFRKKHLFSSTENLAAGSWKEPAEGGGLSSDRQLSESSTKDSLKSMTLPSYRPAPLVSGDLRENMAPANSEATKEAKESKKPESRRSSLLSLMTGKKDVAKGSEGENPLTVPGREKEGMLMGVKPGEDASGPAEDLVRRSEKDTAAVVSRQGSSLNLFEDVQITEPEAEPESKSEPRPPISSPRAPQTRAVKPRLEVSPEAQPTARLPSPTDSPSSLPPLPSSSGQASVPSELGHGADTQSSESPSVFSSLSSPIAAPISTSTPIESWPLVDRGQAKSEGPPLLPKAELQTESLTPVPNSGSSALGSLFKQPSFPANKGTEDSLMGRTRETGTEKNTSSLELEESLPEQPETGRQEEELPRFPCKKQDYSPSSGEAQEVPFALSLSSDGAVSPVGELAAGGDRDLESQAGSLVESKARDAAEEVAPPLPMGASVPSIDSMMRKLEEMGLNLRKDQKKTKKRVSFSEQLFTEEAVAGAALLVEGHSSCPQELNPAWSVAGNASDGEPPESPHAEDSERESVTTPGPATCGAPASPADHLLLPSQEESFSEVPMSEASSAKDTPLFRMEGEDALVTQYQSKASDHEGLLSDPLSDLQLVSDFKSPIMADLNLSLPSIPEVASDDERIDQVEDDGDQVEDDGETAKSSTLDIGALSLGLVVPCPERGKGPSGEADRLVLGEGLCDFRLQAPQASVTAPSEQTTEFGIHKPHLGKSSSLDKQLPGPSGGEEEKPMGNGSPSPPPGTSLDNPVPSPSPSEIFPVTHSFPSSAHSDTHHTSTAESQKKATAEGSAGRVENFGKRKPLLQAWVSPSETHPVSAQPGAGTGSAKHRLHPVKPMNAMATKVANCSLGTATIISENLNNEVMMKKYSPSDPAFAYAQLTHDELIQLVLKQKETISKKEFQVRELEDYIDNLLVRVMEETPNILRIPTQVGKKAGKM | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MSLMVSAGRGLGA --CCCCCCCCCCCCC | 15.84 | 30108239 | |
| 6 (in isoform 2) | Phosphorylation | - | 15.84 | 29507054 | |
| 8 (in isoform 2) | Phosphorylation | - | 19.38 | 30153514 | |
| 9 | Methylation | SLMVSAGRGLGAVWS CCCCCCCCCCCCCCC | 36.56 | 115387261 | |
| 13 (in isoform 1) | Phosphorylation | - | 12.49 | - | |
| 13 (in isoform 2) | Phosphorylation | - | 12.49 | 29507054 | |
| 14 (in isoform 1) | Phosphorylation | - | 5.02 | - | |
| 15 (in isoform 1) | Phosphorylation | - | 9.69 | - | |
| 21 (in isoform 1) | Phosphorylation | - | 19.98 | - | |
| 51 | 2-Hydroxyisobutyrylation | VIQVGKEKYATSVSE EEEECCCEEEECCCH | 43.61 | - | |
| 83 (in isoform 1) | Phosphorylation | - | 17.17 | - | |
| 87 (in isoform 1) | Phosphorylation | - | 15.43 | - | |
| 129 | Acetylation | KTQWYKLKSKPGKKD CCCEEECCCCCCCCC | 52.89 | 18525541 | |
| 131 | Acetylation | QWYKLKSKPGKKDKE CEEECCCCCCCCCCC | 57.09 | 18525549 | |
| 154 | Phosphorylation | QFMRNNMTASMFDLS HHHHHCCCHHHHCCC | 20.08 | 30266825 | |
| 156 | Phosphorylation | MRNNMTASMFDLSMK HHHCCCHHHHCCCCC | 15.71 | 29255136 | |
| 161 | Phosphorylation | TASMFDLSMKDKSRN CHHHHCCCCCCCCCC | 26.15 | 30266825 | |
| 184 | Phosphorylation | IKGKNKDSGSDTASA HCCCCCCCCCCCCCC | 41.63 | 30266825 | |
| 186 | Phosphorylation | GKNKDSGSDTASAII CCCCCCCCCCCCCCC | 35.42 | 30266825 | |
| 188 | Phosphorylation | NKDSGSDTASAIIPS CCCCCCCCCCCCCCC | 24.98 | 30266825 | |
| 190 | Phosphorylation | DSGSDTASAIIPSTT CCCCCCCCCCCCCCC | 23.30 | 30266825 | |
| 195 | Phosphorylation | TASAIIPSTTPSVDS CCCCCCCCCCCCCCC | 34.21 | 30266825 | |
| 196 | Phosphorylation | ASAIIPSTTPSVDSD CCCCCCCCCCCCCCC | 37.05 | 30266825 | |
| 197 | Phosphorylation | SAIIPSTTPSVDSDD CCCCCCCCCCCCCCC | 20.22 | 30266825 | |
| 199 | Phosphorylation | IIPSTTPSVDSDDES CCCCCCCCCCCCCCH | 36.14 | 29255136 | |
| 202 | Phosphorylation | STTPSVDSDDESVVK CCCCCCCCCCCHHHC | 44.82 | 29255136 | |
| 206 | Phosphorylation | SVDSDDESVVKDKKK CCCCCCCHHHCCHHH | 38.92 | 29255136 | |
| 218 | Ubiquitination | KKKKSKIKTLLSKSN HHHHHHHHHHHCCCC | 36.54 | 29967540 | |
| 219 | Phosphorylation | KKKSKIKTLLSKSNL HHHHHHHHHHCCCCC | 36.08 | 21712546 | |
| 222 | Phosphorylation | SKIKTLLSKSNLQKT HHHHHHHCCCCCCCC | 36.83 | 29978859 | |
| 224 | Phosphorylation | IKTLLSKSNLQKTPL HHHHHCCCCCCCCCC | 39.12 | 29978859 | |
| 229 | Phosphorylation | SKSNLQKTPLSQSMS CCCCCCCCCCHHHCC | 19.26 | 30266825 | |
| 232 | Phosphorylation | NLQKTPLSQSMSVLP CCCCCCCHHHCCCCC | 22.78 | 23401153 | |
| 234 | Phosphorylation | QKTPLSQSMSVLPTS CCCCCHHHCCCCCCC | 15.06 | 25159151 | |
| 236 | Phosphorylation | TPLSQSMSVLPTSKP CCCHHHCCCCCCCCC | 26.25 | 30266825 | |
| 240 | Phosphorylation | QSMSVLPTSKPEKVL HHCCCCCCCCCCEEE | 45.26 | 21955146 | |
| 241 | Phosphorylation | SMSVLPTSKPEKVLL HCCCCCCCCCCEEEE | 44.25 | 25159151 | |
| 266 | Phosphorylation | EDDNEDESSSASDVM CCCCCCCCCCHHHHH | 41.75 | 26471730 | |
| 267 | Phosphorylation | DDNEDESSSASDVMS CCCCCCCCCHHHHHH | 28.07 | 30576142 | |
| 268 | Phosphorylation | DNEDESSSASDVMSH CCCCCCCCHHHHHHC | 40.86 | 26471730 | |
| 270 | Phosphorylation | EDESSSASDVMSHKR CCCCCCHHHHHHCCC | 32.46 | 26471730 | |
| 274 | Phosphorylation | SSASDVMSHKRTAST CCHHHHHHCCCCCCC | 26.21 | 26471730 | |
| 278 | Phosphorylation | DVMSHKRTASTDLKQ HHHHCCCCCCCCHHH | 29.75 | 27794612 | |
| 280 | Phosphorylation | MSHKRTASTDLKQLN HHCCCCCCCCHHHHH | 23.11 | 23401153 | |
| 281 | Phosphorylation | SHKRTASTDLKQLNQ HCCCCCCCCHHHHHC | 42.77 | 30266825 | |
| 292 | Phosphorylation | QLNQVNFTLPKKEGL HHHCCCCCCCHHHCH | 36.63 | 25159151 | |
| 296 | 2-Hydroxyisobutyrylation | VNFTLPKKEGLSFLG CCCCCCHHHCHHHHC | 55.89 | - | |
| 296 | Ubiquitination | VNFTLPKKEGLSFLG CCCCCCHHHCHHHHC | 55.89 | 29967540 | |
| 296 (in isoform 1) | Phosphorylation | - | 55.89 | - | |
| 300 | Phosphorylation | LPKKEGLSFLGGLRS CCHHHCHHHHCCCCC | 29.31 | 25159151 | |
| 307 | Phosphorylation | SFLGGLRSKNDVLSR HHHCCCCCCCCCCCC | 40.63 | 23312004 | |
| 313 | Phosphorylation | RSKNDVLSRSNVCIN CCCCCCCCCCCEEEC | 33.25 | 22496350 | |
| 315 | Phosphorylation | KNDVLSRSNVCINGN CCCCCCCCCEEECCC | 30.18 | 21945579 | |
| 325 | Phosphorylation | CINGNHVYLEQPEAK EECCCEEEECCCCCC | 9.29 | 21945579 | |
| 338 | Phosphorylation | AKGEIKDSSPSSSPS CCCCCCCCCCCCCCC | 38.86 | 25159151 | |
| 339 | Phosphorylation | KGEIKDSSPSSSPSP CCCCCCCCCCCCCCC | 38.65 | 29255136 | |
| 341 | Phosphorylation | EIKDSSPSSSPSPKG CCCCCCCCCCCCCCC | 45.45 | 22617229 | |
| 342 | Phosphorylation | IKDSSPSSSPSPKGF CCCCCCCCCCCCCCC | 50.05 | 29255136 | |
| 343 | Phosphorylation | KDSSPSSSPSPKGFR CCCCCCCCCCCCCCC | 33.46 | 29255136 | |
| 345 | Phosphorylation | SSPSSSPSPKGFRKK CCCCCCCCCCCCCHH | 40.99 | 29255136 | |
| 352 | Ubiquitination | SPKGFRKKHLFSSTE CCCCCCHHHCCCCCC | 41.08 | 29967540 | |
| 356 | Phosphorylation | FRKKHLFSSTENLAA CCHHHCCCCCCCCCC | 42.59 | 22167270 | |
| 357 | Phosphorylation | RKKHLFSSTENLAAG CHHHCCCCCCCCCCC | 32.19 | 22167270 | |
| 358 | Phosphorylation | KKHLFSSTENLAAGS HHHCCCCCCCCCCCC | 27.91 | 22167270 | |
| 365 | Phosphorylation | TENLAAGSWKEPAEG CCCCCCCCCCCCCCC | 30.19 | 23927012 | |
| 376 | Phosphorylation | PAEGGGLSSDRQLSE CCCCCCCCCCHHHCC | 33.20 | 23927012 | |
| 377 | Phosphorylation | AEGGGLSSDRQLSES CCCCCCCCCHHHCCC | 41.68 | 23403867 | |
| 380 (in isoform 2) | Phosphorylation | - | 55.09 | 25159151 | |
| 381 (in isoform 2) | Phosphorylation | - | 6.81 | 25159151 | |
| 382 | Phosphorylation | LSSDRQLSESSTKDS CCCCHHHCCCCCHHH | 27.39 | 21406692 | |
| 384 | Phosphorylation | SDRQLSESSTKDSLK CCHHHCCCCCHHHHH | 39.67 | 28450419 | |
| 385 | Phosphorylation | DRQLSESSTKDSLKS CHHHCCCCCHHHHHH | 35.11 | 26657352 | |
| 386 | Phosphorylation | RQLSESSTKDSLKSM HHHCCCCCHHHHHHC | 48.42 | 28450419 | |
| 387 | Ubiquitination | QLSESSTKDSLKSMT HHCCCCCHHHHHHCC | 47.47 | 27667366 | |
| 389 | Phosphorylation | SESSTKDSLKSMTLP CCCCCHHHHHHCCCC | 38.97 | 25159151 | |
| 391 | Ubiquitination | SSTKDSLKSMTLPSY CCCHHHHHHCCCCCC | 41.98 | 29967540 | |
| 392 | Phosphorylation | STKDSLKSMTLPSYR CCHHHHHHCCCCCCC | 23.46 | 25159151 | |
| 394 | Phosphorylation | KDSLKSMTLPSYRPA HHHHHHCCCCCCCCC | 42.48 | 25159151 | |
| 397 | Phosphorylation | LKSMTLPSYRPAPLV HHHCCCCCCCCCCCC | 36.57 | 29978859 | |
| 398 | Phosphorylation | KSMTLPSYRPAPLVS HHCCCCCCCCCCCCC | 20.76 | 29978859 | |
| 405 | Phosphorylation | YRPAPLVSGDLRENM CCCCCCCCCCHHHCC | 33.98 | 23186163 | |
| 424 | Ubiquitination | SEATKEAKESKKPES HHHHHHHHHHCCCHH | 64.71 | 24816145 | |
| 426 | Phosphorylation | ATKEAKESKKPESRR HHHHHHHHCCCHHHH | 45.32 | 24719451 | |
| 431 | Phosphorylation | KESKKPESRRSSLLS HHHCCCHHHHHHHHH | 41.33 | 24719451 | |
| 434 | Phosphorylation | KKPESRRSSLLSLMT CCCHHHHHHHHHHHH | 24.99 | 29255136 | |
| 435 | Phosphorylation | KPESRRSSLLSLMTG CCHHHHHHHHHHHHC | 31.36 | 29255136 | |
| 438 | Phosphorylation | SRRSSLLSLMTGKKD HHHHHHHHHHHCCCC | 22.76 | 25159151 | |
| 441 | Phosphorylation | SSLLSLMTGKKDVAK HHHHHHHHCCCCHHC | 51.66 | 23927012 | |
| 443 | 2-Hydroxyisobutyrylation | LLSLMTGKKDVAKGS HHHHHHCCCCHHCCC | 36.31 | - | |
| 443 | Acetylation | LLSLMTGKKDVAKGS HHHHHHCCCCHHCCC | 36.31 | 30591741 | |
| 448 | Ubiquitination | TGKKDVAKGSEGENP HCCCCHHCCCCCCCC | 63.92 | 27667366 | |
| 450 | Phosphorylation | KKDVAKGSEGENPLT CCCHHCCCCCCCCCC | 41.54 | 28348404 | |
| 463 | 2-Hydroxyisobutyrylation | LTVPGREKEGMLMGV CCCCCCCCCCCEECC | 59.20 | - | |
| 464 (in isoform 1) | Phosphorylation | - | 45.11 | - | |
| 466 | Sulfoxidation | PGREKEGMLMGVKPG CCCCCCCCEECCCCC | 2.15 | 21406390 | |
| 471 | Ubiquitination | EGMLMGVKPGEDASG CCCEECCCCCCCCCC | 41.39 | 24816145 | |
| 477 | Phosphorylation | VKPGEDASGPAEDLV CCCCCCCCCCHHHHH | 58.60 | 25159151 | |
| 483 (in isoform 1) | Phosphorylation | - | 2.13 | - | |
| 487 | Phosphorylation | AEDLVRRSEKDTAAV HHHHHHHCHHCHHEE | 38.13 | - | |
| 489 | 2-Hydroxyisobutyrylation | DLVRRSEKDTAAVVS HHHHHCHHCHHEEEE | 62.72 | - | |
| 489 | Ubiquitination | DLVRRSEKDTAAVVS HHHHHCHHCHHEEEE | 62.72 | 24816145 | |
| 491 | Phosphorylation | VRRSEKDTAAVVSRQ HHHCHHCHHEEEECC | 27.81 | 28450419 | |
| 496 | Phosphorylation | KDTAAVVSRQGSSLN HCHHEEEECCCCCCC | 16.58 | 29255136 | |
| 500 | Phosphorylation | AVVSRQGSSLNLFED EEEECCCCCCCCEEC | 24.26 | 22617229 | |
| 501 | Phosphorylation | VVSRQGSSLNLFEDV EEECCCCCCCCEECE | 28.27 | 30278072 | |
| 511 | Phosphorylation | LFEDVQITEPEAEPE CEECEECCCCCCCCC | 28.53 | 22115753 | |
| 519 | Phosphorylation | EPEAEPESKSEPRPP CCCCCCCCCCCCCCC | 52.80 | 22817900 | |
| 521 | Phosphorylation | EAEPESKSEPRPPIS CCCCCCCCCCCCCCC | 63.21 | 25159151 | |
| 528 | Phosphorylation | SEPRPPISSPRAPQT CCCCCCCCCCCCCCC | 39.81 | 23401153 | |
| 528 (in isoform 3) | Phosphorylation | - | 39.81 | 25159151 | |
| 529 | Phosphorylation | EPRPPISSPRAPQTR CCCCCCCCCCCCCCC | 21.08 | 30266825 | |
| 529 (in isoform 3) | Phosphorylation | - | 21.08 | 25159151 | |
| 535 | Phosphorylation | SSPRAPQTRAVKPRL CCCCCCCCCCCCCCE | 21.38 | 30619164 | |
| 541 (in isoform 1) | Ubiquitination | - | 37.45 | 21906983 | |
| 545 | Phosphorylation | VKPRLEVSPEAQPTA CCCCEECCCCCCCCC | 13.98 | 25159151 | |
| 551 | Phosphorylation | VSPEAQPTARLPSPT CCCCCCCCCCCCCCC | 16.60 | 27050516 | |
| 565 (in isoform 1) | Ubiquitination | - | 30.26 | - | |
| 577 | Ubiquitination | SSGQASVPSELGHGA CCCCCCCCHHHCCCC | 21.42 | 23503661 | |
| 578 | Ubiquitination | SGQASVPSELGHGAD CCCCCCCHHHCCCCC | 43.21 | 23503661 | |
| 578 (in isoform 3) | Ubiquitination | - | 43.21 | 21906983 | |
| 602 | Ubiquitination | FSSLSSPIAAPISTS HHCCCCCCCCCCCCC | 5.73 | 23503661 | |
| 604 | Ubiquitination | SLSSPIAAPISTSTP CCCCCCCCCCCCCCC | 11.59 | 23503661 | |
| 625 | Phosphorylation | VDRGQAKSEGPPLLP CCCCCCCCCCCCCCC | 53.28 | 25159151 | |
| 638 | Phosphorylation | LPKAELQTESLTPVP CCCHHEECCCCCCCC | 39.92 | 21406692 | |
| 642 | Phosphorylation | ELQTESLTPVPNSGS HEECCCCCCCCCCCC | 31.36 | 24719451 | |
| 644 | Ubiquitination | QTESLTPVPNSGSSA ECCCCCCCCCCCCHH | 6.21 | 33845483 | |
| 648 | Ubiquitination | LTPVPNSGSSALGSL CCCCCCCCCHHHHHH | 30.49 | 24816145 | |
| 654 | Phosphorylation | SGSSALGSLFKQPSF CCCHHHHHHHCCCCC | 26.86 | 24719451 | |
| 660 | Phosphorylation | GSLFKQPSFPANKGT HHHHCCCCCCCCCCC | 41.17 | 26657352 | |
| 670 | Phosphorylation | ANKGTEDSLMGRTRE CCCCCCCCCCCCCCC | 17.64 | 21815630 | |
| 684 | Phosphorylation | ETGTEKNTSSLELEE CCCCCCCCCCCCCHH | 30.66 | 17192257 | |
| 685 | Phosphorylation | TGTEKNTSSLELEES CCCCCCCCCCCCHHH | 42.17 | 17192257 | |
| 686 | Phosphorylation | GTEKNTSSLELEESL CCCCCCCCCCCHHHC | 24.67 | 17192257 | |
| 692 | Phosphorylation | SSLELEESLPEQPET CCCCCHHHCCCCCCC | 39.59 | 17192257 | |
| 717 | Phosphorylation | PCKKQDYSPSSGEAQ CCCCCCCCCCCCCCC | 26.96 | 25921289 | |
| 719 | Phosphorylation | KKQDYSPSSGEAQEV CCCCCCCCCCCCCCC | 45.06 | 28348404 | |
| 720 | Phosphorylation | KQDYSPSSGEAQEVP CCCCCCCCCCCCCCC | 44.00 | 28348404 | |
| 731 | Phosphorylation | QEVPFALSLSSDGAV CCCCEEEEECCCCCC | 23.83 | 28122231 | |
| 733 | Phosphorylation | VPFALSLSSDGAVSP CCEEEEECCCCCCCC | 24.02 | 28122231 | |
| 734 | Phosphorylation | PFALSLSSDGAVSPV CEEEEECCCCCCCCH | 45.41 | 28122231 | |
| 739 | Phosphorylation | LSSDGAVSPVGELAA ECCCCCCCCHHHHHC | 17.21 | 26657352 | |
| 754 | Phosphorylation | GGDRDLESQAGSLVE CCCCCHHHHHHHHHH | 32.40 | 25159151 | |
| 758 | Phosphorylation | DLESQAGSLVESKAR CHHHHHHHHHHHHHH | 32.05 | 25159151 | |
| 762 | Phosphorylation | QAGSLVESKARDAAE HHHHHHHHHHHHHHH | 24.92 | 20873877 | |
| 783 | Phosphorylation | PMGASVPSIDSMMRK CCCCCCCCHHHHHHH | 36.55 | 22210691 | |
| 786 | Phosphorylation | ASVPSIDSMMRKLEE CCCCCHHHHHHHHHH | 16.89 | 22210691 | |
| 800 | Acetylation | EMGLNLRKDQKKTKK HHCCCCCCCHHHHHH | 68.62 | 20167786 | |
| 803 | Acetylation | LNLRKDQKKTKKRVS CCCCCCHHHHHHCCC | 72.97 | 20167786 | |
| 880 | Phosphorylation | ATCGAPASPADHLLL CCCCCCCCHHCCCCC | 21.40 | - | |
| 908 | Phosphorylation | EASSAKDTPLFRMEG HHHCCCCCCCEEEEC | 22.61 | 21815630 | |
| 921 | Phosphorylation | EGEDALVTQYQSKAS ECCCEEHHHHHHCCC | 23.55 | 29978859 | |
| 923 | Phosphorylation | EDALVTQYQSKASDH CCEEHHHHHHCCCCC | 12.85 | 29978859 | |
| 925 | Phosphorylation | ALVTQYQSKASDHEG EEHHHHHHCCCCCCC | 25.84 | 21815630 | |
| 928 | Phosphorylation | TQYQSKASDHEGLLS HHHHHCCCCCCCCCC | 43.14 | 25159151 | |
| 935 | Phosphorylation | SDHEGLLSDPLSDLQ CCCCCCCCCCHHHHH | 42.07 | 25159151 | |
| 939 | Phosphorylation | GLLSDPLSDLQLVSD CCCCCCHHHHHHHHC | 41.48 | 24626860 | |
| 945 | Phosphorylation | LSDLQLVSDFKSPIM HHHHHHHHCCCCCHH | 46.02 | 24626860 | |
| 958 | Phosphorylation | IMADLNLSLPSIPEV HHHCCCCCCCCCHHC | 36.84 | 20873877 | |
| 961 | Phosphorylation | DLNLSLPSIPEVASD CCCCCCCCCHHCCCC | 56.95 | 30278072 | |
| 967 | Phosphorylation | PSIPEVASDDERIDQ CCCHHCCCCCHHCCC | 51.26 | 30278072 | |
| 1038 | Phosphorylation | RLQAPQASVTAPSEQ EEECCCCCEECCCCC | 18.11 | 28555341 | |
| 1070 | Phosphorylation | DKQLPGPSGGEEEKP CCCCCCCCCCCCCCC | 66.40 | 27794612 | |
| 1131 | Phosphorylation | AESQKKATAEGSAGR HHHHHHHHHCCCCHH | 33.84 | 28555341 | |
| 1135 | Phosphorylation | KKATAEGSAGRVENF HHHHHCCCCHHHHHC | 21.03 | 25159151 | |
| 1154 | Phosphorylation | PLLQAWVSPSETHPV CCEEECCCCCCCCCC | 16.41 | 18691976 | |
| 1156 | Phosphorylation | LQAWVSPSETHPVSA EEECCCCCCCCCCCC | 47.85 | 28348404 | |
| 1158 | Phosphorylation | AWVSPSETHPVSAQP ECCCCCCCCCCCCCC | 35.50 | 26434776 | |
| 1162 | Phosphorylation | PSETHPVSAQPGAGT CCCCCCCCCCCCCCC | 26.15 | 26434776 | |
| 1169 | Phosphorylation | SAQPGAGTGSAKHRL CCCCCCCCCCCCCCC | 27.68 | 26434776 | |
| 1171 | Phosphorylation | QPGAGTGSAKHRLHP CCCCCCCCCCCCCCC | 33.70 | 26434776 | |
| 1187 | Phosphorylation | KPMNAMATKVANCSL CCCCHHHHHHHCCCC | 16.99 | - | |
| 1193 | Phosphorylation | ATKVANCSLGTATII HHHHHCCCCCCEEEE | 29.64 | 25159151 | |
| 1196 | Phosphorylation | VANCSLGTATIISEN HHCCCCCCEEEEECC | 26.39 | 25159151 | |
| 1198 | Phosphorylation | NCSLGTATIISENLN CCCCCCEEEEECCCC | 20.77 | 25627689 | |
| 1211 | Ubiquitination | LNNEVMMKKYSPSDP CCCHHHHHCCCCCCH | 30.39 | 23503661 | |
| 1212 | Ubiquitination | NNEVMMKKYSPSDPA CCHHHHHCCCCCCHH | 32.82 | 2190698 | |
| 1212 (in isoform 4) | Ubiquitination | - | 32.82 | 21906983 | |
| 1214 | Phosphorylation | EVMMKKYSPSDPAFA HHHHHCCCCCCHHHH | 27.14 | 25159151 | |
| 1216 | Phosphorylation | MMKKYSPSDPAFAYA HHHCCCCCCHHHHHH | 50.73 | - | |
| 1226 | Phosphorylation | AFAYAQLTHDELIQL HHHHHHCCHHHHHHH | 18.39 | - | |
| 1236 | Ubiquitination | ELIQLVLKQKETISK HHHHHHHHCCCCCCH | 52.42 | 23503661 | |
| 1238 | Ubiquitination | IQLVLKQKETISKKE HHHHHHCCCCCCHHH | 56.06 | 23503661 | |
| 1254 | Phosphorylation | QVRELEDYIDNLLVR CHHHHHHHHHHHHHH | 10.78 | 29978859 | |
| 1274 | Phosphorylation | PNILRIPTQVGKKAG CCCEECCCHHHHHCC | 33.25 | 26657352 | |
| 1278 | 2-Hydroxyisobutyrylation | RIPTQVGKKAGKM-- ECCCHHHHHCCCC-- | 40.36 | - | |
| 1278 | Ubiquitination | RIPTQVGKKAGKM-- ECCCHHHHHCCCC-- | 40.36 | 33845483 | |
| 1282 | Ubiquitination | QVGKKAGKM------ HHHHHCCCC------ | 46.42 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 234 | S | Phosphorylation | Kinase | MARK2 | Q7KZI7 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RFIP1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RFIP1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RFIP1_HUMAN | RAB11FIP1 | physical | 12364336 | |
| RFIP2_HUMAN | RAB11FIP2 | physical | 12364336 | |
| RB11A_HUMAN | RAB11A | physical | 11495908 | |
| RAB14_HUMAN | RAB14 | physical | 19702578 | |
| ASAP1_HUMAN | ASAP1 | physical | 18685082 | |
| NOLC1_HUMAN | NOLC1 | physical | 28514442 | |
| 1433Z_HUMAN | YWHAZ | physical | 28514442 | |
| 1433G_HUMAN | YWHAG | physical | 28514442 | |
| CBY1_HUMAN | CBY1 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-357 ANDSER-545, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199; SER-202; SER-338;SER-343; SER-345 AND SER-545, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202; SER-338; SER-339;SER-341; SER-342; SER-343; SER-345; SER-435; SER-477 AND SER-545, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; SER-435; SER-477;SER-500; SER-501; SER-545; THR-684; SER-685; SER-686; SER-692;SER-754; SER-758 AND SER-1135, AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-496, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-357, AND MASSSPECTROMETRY. | |